These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19571374)

  • 1. Pharmacokinetics of ceftriaxione, a third-generation cephalosporin, in pediatric patients.
    Fukumoto K; Aida S; Oishi T; Ueno K
    Biol Pharm Bull; 2009 Jul; 32(7):1139-41. PubMed ID: 19571374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy.
    Goto K; Sato Y; Yasuda N; Hidaka S; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Itoh H
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):625-631. PubMed ID: 27497425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.
    Iida S; Kinoshita H; Kawanishi T; Hayashi M
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):107-15. PubMed ID: 19645220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and clinical evaluation of ceftriaxone in pediatric surgery].
    Yura J; Kamiya Y; Tsuruga N; Narita H; Suzuki T
    Jpn J Antibiot; 1988 Feb; 41(2):165-72. PubMed ID: 3373737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    Vet Res Commun; 2004 May; 28(4):331-8. PubMed ID: 15222737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections].
    Okura K; Yamamoto H; Yamaoka K; Kubo K; Mitsuyoshi I; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].
    Motohiro T; Oda K; Aramaki M; Tanaka K; Kawakami A; Shimada Y; Koga T; Tomita S; Sakata Y; Fujimoto T
    Jpn J Antibiot; 1988 Mar; 41(3):276-305. PubMed ID: 3404647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic and clinical studies on ceftriaxone in the perinatal period].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1988 Feb; 41(2):201-9. PubMed ID: 3373740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the pharmacokinetics of ceftriaxone in neonates].
    Sunakawa K; Sato Y
    Jpn J Antibiot; 1988 Feb; 41(2):128-32. PubMed ID: 3373735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical evaluation of ceftriaxone in the field of pediatrics].
    Satoh Y; Iwata S; Akita H; Murai T; Hayano S; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Nov; 37(11):2034-48. PubMed ID: 6098700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
    Deguchi K; Fukuyama S; Nishimura Y; Nishike A; Fukumoto T; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N
    Jpn J Antibiot; 1984 Sep; 37(9):1701-13. PubMed ID: 6096585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation on ceftriaxone in the pediatric field].
    Nakazawa S; Satoh H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K
    Jpn J Antibiot; 1984 Nov; 37(11):2083-101. PubMed ID: 6098703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Free concentration and protein binding of ceftriaxone].
    Saionji K; Miyake N; Miyake K; Igari J; Kobayashi I; Satoh Y
    Jpn J Antibiot; 1992 Feb; 45(2):136-42. PubMed ID: 1613966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of ceftriaxone when administered once daily for respiratory tract infections in patients with advanced ages].
    Takizawa S; Yanase K; Hashizume I; Kasamatsu N; Tachibana A; Ogisu N; Okazawa M
    Jpn J Antibiot; 1992 Jun; 45(6):681-6. PubMed ID: 1507399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.